Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.
Glucagon-like peptide 1 [7-36 amide] (GLP-1) has been shown to enhance insulin secretion in healthy and type II diabetic humans, and to increase glucose disposal in type I diabetic patients. To further define its action on glucose kinetics, we studied six healthy subjects who received either GLP-1 (...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
1994
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294382/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8182159/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117225 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|